SLSBio(Specialty Lab Solution Bio) Co., Ltd Logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd

Offers lab services and manufactures diagnostics for the pharma and biotech sectors.

246250 | KO

Overview

Corporate Details

ISIN(s):
KR7246250005
LEI:
Country:
South Korea
Address:
경기도 수원시 영통구 창룡대로 260, 광교센트럴비즈타워7층 (이의동), 수원시

Description

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a company specializing in laboratory solutions and support services for the pharmaceutical and biotechnology sectors. Its primary offerings include pharmaceutical quality control testing, clinical trial sample analysis, bioequivalence studies, drug stability testing, and new drug development support. In addition to its service portfolio, the company develops and manufactures diagnostic technologies, reagents, and other biological agents, supporting various stages of the drug development and commercialization lifecycle.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-10-13 00:00
상장폐지결정(코스닥시장 이전상장)
Korean 8.7 KB
2023-10-11 00:00
유상증자또는주식관련사채등의청약결과(자율공시)(일반공모 유상증자)
Korean 8.1 KB
2023-09-26 00:00
유상증자최종발행가액확정(일반공모)
Korean 5.1 KB
2023-09-26 00:00
[발행조건확정]증권신고서(지분증권)
Korean 343.2 KB
2023-09-26 00:00
[기재정정]투자설명서
Korean 2.2 MB
2023-09-26 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 120.3 KB
2023-09-15 00:00
투자설명서
Korean 1.8 MB
2023-09-12 00:00
[기재정정]증권신고서(지분증권) (2023.09)
Korean 1.9 MB
2023-08-31 00:00
[기재정정]증권신고서(지분증권) (2023.09)
Korean 2.2 MB
2023-08-31 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 134.1 KB
2023-08-21 00:00
주요사항보고서(유상증자결정)
Korean 68.6 KB
2023-08-21 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 70.4 KB
2023-08-18 00:00
증권신고서(지분증권) (2023.09)
Korean 1.8 MB
2023-08-16 00:00
특허권취득(자율공시)
Korean 4.3 KB
2023-06-29 00:00
기타주요경영사항(자율공시)(코스닥시장 상장예비심사 승인)
Korean 4.9 KB

Automate Your Workflow. Get a real-time feed of all SLSBio(Specialty Lab Solution Bio) Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SLSBio(Specialty Lab Solution Bio) Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SLSBio(Specialty Lab Solution Bio) Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.